Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Citations 0
From the Centers for Disease Control and Prevention
April 15, 1998

Progress Toward Elimination of Measles From the Americas

Author Affiliations

Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1998American Medical AssociationThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

JAMA. 1998;279(15):1154-1155. doi:10.1001/jama.279.15.1154

MMWR. 1998;47:189-193

2 figures omitted

In 1994, the Pan American Health Organization (PAHO) established the goal of eliminating measles from the Western Hemisphere by 2000.1 To reach this goal, PAHO developed a measles-elimination strategy that includes three vaccination components ("catch-up," "keep-up," and "follow-up"*) and integrated epidemiologic and laboratory surveillance.25 The aim of the strategy is to achieve and maintain high levels of measles immunity among infants and children and detect all chains of transmission of measles virus through careful surveillance. This report updates measles surveillance data through February 1998 and summarizes the impact of elimination strategies on measles in the Americas.

Each country in the Region of the Americas, except the United States, the French Antilles, and the Netherlands Antilles, conducted measles "catch-up" campaigns during 1987-1994. Vaccination coverage achieved during these campaigns was 94% regionwide, and country-specific coverage ranged from 71% to 99%. In addition, routine measles vaccination coverage among infants increased from 42% in 1980 to 86% in 1996. In 1996, a total of 27 (57%) of 47 countries and territories achieved >90% coverage, 15 (32%) achieved 80%-90% coverage, and five (11%) achieved <80% coverage in their routine vaccination services. Since 1994, a total of 26 (55%) of 47 countries and territories also have conducted "follow-up" vaccination campaigns. The annual number of reported measles cases in the region decreased substantially. In 1996, a record low 2109 confirmed measles cases was reported from the region. Of the 47 countries and territories that provided weekly measles surveillance data to PAHO, 29 (62%) reported no confirmed cases, and 38 (81%) reported ≤10 cases. Most of the region was free of measles virus circulation during 1996.

In 1997, however, a resurgence of measles occurred in the region. Provisional data from January 1997 through February 1998 indicate that 88,485 suspected measles cases were reported from the countries. Of these, 27,635 (31%) have been confirmed, 33,120 (37%) have been discarded, and 27,730 (31%) are under investigation. Of the 27,635 confirmed cases in 1997, a total of 26,919 (97%) were confirmed by laboratory testing or linked epidemiologically to a laboratory-confirmed case, and 716 (3%) were confirmed clinically, without laboratory investigation. Brazil (26,348 confirmed cases) and Canada (570 confirmed cases) accounted for 97% of the total confirmed cases in the region. The United States (135 cases), Paraguay (198), Guadeloupe (116), Argentina (96), Chile (59), Venezuela (27), and Costa Rica (15) all reported >10 confirmed measles cases during 1997.


Of the 26,348 confirmed cases reported from Brazil, 20,186 (77%) were reported from São Paulo, the only state that did not conduct a follow-up measles vaccination campaign in 1995. Most cases during this outbreak occurred in persons residing in the greater São Paulo metropolitan area. Of the 19,322 confirmed measles cases reported from São Paulo for which patient age was known, 9938 (51%) occurred in persons aged 20-29 years. The highest age-specific incidence rates were reported for infants aged <1 year (456 cases per 100,000 population), young adults aged 20-29 years (156), and children aged 1-4 years (45).

Many cases occurred among young adults who were members of groups congregating in enclosed environments, including male migrant workers from rural areas, students, health-care workers, tourist industry workers, and military recruits. Twenty measles-related deaths were reported; 17 (85%) occurred among infants aged <1 year.

Genomic sequencing of virus isolates from Brazil, performed by CDC's Respiratory and Enteric Viruses Branch, demonstrated that the virus circulating in São Paulo was similar to virus isolates recently obtained from Western Europe, suggesting that the virus responsible for the outbreak may have been imported from Europe. The measles virus circulating in São Paulo spread to almost every other state in Brazil. Other Brazilian states reporting large numbers of measles cases included Bahia (1013 cases), Minas Gerais (626), Ceara (594), Rio de Janeiro (577), Parana (462), and the Federal District (432). Other countries in the region documenting spread from São Paulo were Argentina, Chile, Costa Rica, Paraguay, Peru, and the United States. Epidemiologic investigation is under way to determine specific risk factors for measles in São Paulo.

Several factors may have facilitated widespread measles transmission in the greater São Paulo metropolitan area in 1997. First, the lack of a timely follow-up vaccination campaign in 1995 for children aged 1-4 years, combined with low routine vaccination coverage among infants, resulted in rapid accumulation of susceptible preschool-aged children. Second, the presence of large numbers of susceptible young adults who had not had natural measles infection or measles vaccination increased the risk for a measles outbreak. Third, measles virus was probably imported from Europe into São Paulo. Finally, the high population density of São Paulo greatly facilitated contact between infected and susceptible persons.6


During 1997, Canada reported 570 confirmed measles cases. Of these, >300 cases occurred in a university community in British Columbia. Most cases occurred in young adults who had been vaccinated previously with one dose of measles vaccine. Genomic analysis of measles virus obtained from patients during this outbreak suggested that measles virus circulating in British Columbia was imported from Europe. Measles virus from the outbreak in British Columbia spread to the neighboring province of Alberta, where 245 cases were reported; most cases occurred in school-aged children who were vaccinated previously with one dose of measles vaccine.

United States

During 1997, the United States reported a provisional total of 135 confirmed measles cases. This is the lowest number of cases ever reported and is less than half the previous record low incidence of 309 cases in 1995. During a 7-week period, no indigenous measles cases were reported, suggesting an interruption of measles transmission. Fifty-seven (42%) of the reported cases were documented as international importations, primarily from Europe and Asia. In 1995 and 1996, no documented importations from Latin American or Caribbean countries to the United States were reported.† In 1997, however, five confirmed imported measles cases were reported from Brazil, all from São Paulo. Spread from imported cases was limited, and the largest outbreak in the United States during 1997 comprised eight cases.

Reported by:

Special Program for Vaccines and Immunization, Pan American Health Organization, Washington, DC.

CDC Editorial Note:

Substantial progress has been made toward eliminating measles virus from the Americas. Most countries have implemented PAHO's measles-elimination strategy, and indigenous measles virus circulation has been interrupted in large geographic areas of the region. In addition, improvements have been made in measles surveillance throughout the region, including the development of a regional measles laboratory network with at least one measles reference laboratory in every country.

Although the relative resurgence of measles in the Americas during 1997 represented a major increase over the number of cases reported in 1996, these cases still represented only approximately 10% of those reported in 1990. Moreover, the measles cases reported in the Americas in 1996, the last year for which comparable data were available, represented only 0.3% of the total reported global cases.7 Measles case surveillance data, combined with molecular epidemiologic information provided by PAHO's measles laboratory network, suggest the countries of the Americas are constantly challenged by imported measles virus from other regions of the world in which measles remains endemic.8,9

The outbreak in Brazil demonstrates that the absence of measles virus circulation does not indicate the absence of risk for measles outbreaks. This outbreak highlights several major challenges facing the region. First, the countries of the Americas need to achieve and maintain the highest population immunity level possible in infants and children and to supplement existing strategies by targeting measles vaccination to adolescents and young adults at highest risk for exposure to measles virus. Second, surveillance needs to be strengthened to detect population groups susceptible to measles and possible foci of transmission established by measles importations. Finally, increased efforts for control and regional elimination of measles are needed in other regions of the world to decrease the quantity of measles virus exported to the Americas as a step toward global measles eradication.10

Back to top
Article Information
*Catch-up is defined as a one-time vaccination campaign targeting all children aged 9 months-14 years regardless of history of measles disease or vaccination status; keep-up is defined as routine services aimed at vaccinating >90% of each successive birth cohort; and follow-up is defined as a vaccination campaign conducted at least every 4 years targeting all children aged 1-4 years.
† In 1995, one case that could have been imported from a Latin American country was reported; however, subsequent investigation revealed no evidence of measles transmission in that country.
Pan American Health Organization, Measles elimination by the year 2000. EPI Newsletter. 1994;16 October1- 2
de Quadros  CAOlive  JMHersh  BS  et al.  Measles elimination in the Americas: evolving strategies. JAMA. 1996;275224- 9Article
Arista  SFerraro  DCascio  AVizzi  Edi Stefano  R Detection of IgM antibodies specific for measles virus by capture and indirect enzyme immunoassays. Res Virol. 1995;146225- 32Article
Helfand  RFHeath  JLAnderson  LJ  et al.  Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis. 1997;175195- 9Article
Bellini  WJRota  PA Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis. 1998;429- 35Article
Pan American Health Organization, Update: São Paulo measles outbreak. EPI Newsletter. 1997;19 June1- 2
World Health Organization, Expanded Programme on Immunization Information System—global summary.  Geneva, Switzerland World Health Organization August1997;
Rota  JSHeath  JLRota  PA  et al.  Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis. 1996;17332- 7Article
Vitek  CRRedd  SCRedd  SBHadler  SC Trends in importation of measles to the United States, 1986-1994. JAMA. 1997;2771952- 6Article
CDC, Measles eradication: recommendations from a meeting co-sponsored by the World Health Organization, the Pan American Health Organization, and CDC. MMWR. 1997;46 ((no. RR-11))